Ketamine Therapy in Virginia

Ketamine therapy in Virginia operates under a well-established framework governed by both federal and state-level oversight. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning that any practitioner administering or prescribing it must hold a valid DEA registration. In Virginia, the Virginia Board of Medicine and the Virginia Board of Pharmacy serve as the primary state regulatory bodies overseeing the practice of ketamine-assisted treatment, ensuring that clinics adhere to standards of patient safety, proper documentation, and appropriate clinical protocols.

Virginia law requires that ketamine infusions be administered or directly supervised by a licensed physician, nurse anesthetist (CRNA), or other qualified medical professional operating within their defined scope of practice. Clinics offering ketamine therapy must maintain proper licensure as healthcare facilities where applicable, and practitioners must comply with Virginia's requirements for controlled substance record-keeping, including accurate logs of procurement, dispensing, and patient administration. The state follows federal guidelines requiring secure storage of Schedule III substances and mandates participation in the Virginia Prescription Monitoring Program (PMP), which tracks the prescribing and dispensing of controlled substances to help prevent misuse.

For patients seeking ketamine therapy in Virginia, it is important to understand that treatment is generally provided in one of the following clinical contexts:

• IV ketamine infusion clinics, where subanesthetic doses are administered intravenously for conditions such as treatment-resistant depression, PTSD, anxiety, and chronic pain
• Anesthesiology or surgical settings, where ketamine is used for procedural sedation or pain management
• Integrated mental health practices, where ketamine-assisted psychotherapy may be offered in conjunction with licensed therapists

As the landscape of psychedelic and ketamine-assisted therapies continues to evolve, Virginia practitioners and clinics are expected to stay current with guidance issued by the Virginia Board of Medicine regarding off-label prescribing practices and emerging treatment modalities. Patients are encouraged to verify that any clinic they consider is staffed by board-certified, DEA-registered providers and that informed consent, medical screening, and post-treatment monitoring protocols are clearly in place before beginning treatment.